Phonophoresis
Phonophoresis is the use of ultrasound to enhance the delivery of topically applied drugs. Phonophoresis has been used in an effort to enhance the absorption of topically applied analgesics and anti-inflammatory agents through the therapeutic application of ultrasound.
Phonophoresis has been shown to be ineffective for some treatments, where it did not increase the efficacy of absorption of drugs, or did not improve the outcome more than the use of ultrasound alone.
External links
- Srbely JZ (2008). “Ultrasound in the management of osteoarthritis: part I: a review of the current literature”. JCCA J Can Chiropr Assoc. 52 (1): 30–7. PMC 2258240. PMID 18327300. Unknown parameter
|month=ignored (help) - Darrow H, Schulthies S, Draper D, Ricard M, Measom GJ (1999). “Serum Dexamethasone Levels After Decadron Phonophoresis”. J Athl Train. 34 (4): 338–341. PMC 1323341. PMID 16558583. Unknown parameter
|month=ignored (help) - Hoppenrath T, Ciccone CD (2006). “Is there evidence that phonophoresis is more effective than ultrasound in treating pain associated with lateral epicondylitis?”. Phys Ther. 86 (1): 136–40. PMID 16386068. Unknown parameter
|month=ignored (help)
References
- Bare AC, McAnaw MB, Pritchard AE; et al. (1996). “Phonophoretic delivery of 10% hydrocortisone through the epidermis of humans as determined by serum cortisol concentrations”. Phys Ther. 76 (7): 738–45, discussion 746–9. PMID 8677278. Unknown parameter
|month=ignored (help) - Byl NN (1995). “The use of ultrasound as an enhancer for transcutaneous drug delivery: phonophoresis”. Phys Ther. 75 (6): 539–53. PMID 7770499. Unknown parameter
|month=ignored (help) - Gogstetter DS, Goldsmith LA (1999). “Treatment of cutaneous sarcoidosis using phonophoresis”. J. Am. Acad. Dermatol. 40 (5 Pt 1): 767–9. doi:10.1016/S0190-9622(99)70162-3. PMID 10321609. Unknown parameter
|month=ignored (help)
See also
© 2026 MyEClinic – IFTM Institut für Telematik in der Medizin GmbH